Zebra Capital Management LLC Chroma Dex Corp. Transaction History

Zebra Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.02 - $3.92 $48,871 - $94,840	-24,194 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.74 - $6.7 $4,390 - $7,865	1,174 Added 5.1%	24,194 $90,000
Q2 2021 Aug 16, 2021	BUY	$6.66 - $10.92 $4,908 - $8,048	737 Added 3.31%	23,020 $227,000
Q1 2021 May 17, 2021	SELL	$4.59 - $18.74 $264,126 - $1.08 Million	-57,544 Reduced 72.09%	22,283 $208,000
Q4 2020 Feb 16, 2021	SELL	$3.93 - $5.5 $11,644 - $16,296	-2,963 Reduced 3.58%	79,827 $383,000
Q3 2020 Nov 16, 2020	BUY	$4.01 - $5.56 $224,892 - $311,821	56,083 Added 209.99%	82,790 $332,000
Q2 2020 Aug 14, 2020	SELL	$3.0 - $5.52 $1,869 - $3,438	-623 Reduced 2.28%	26,707 $123,000
Q1 2020 May 15, 2020	SELL	$2.54 - $4.75 $3,528 - $6,597	-1,389 Reduced 4.84%	27,330 $89,000
Q4 2019 Feb 14, 2020	BUY	$2.83 - $4.61 $81,274 - $132,394	28,719 New	28,719 $123,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $375M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.